Exponent : FDA Releases New Acceptable Intake Levels for Nitrosamine Drug Substance-Related Impurities

including deriving acceptable intake limits - as well providing guidance on the implementation of the framework.


The 2023 guidance document provides further clarification and updates...
-Yesterday at 09:27 pm- MarketScreener

Related Keywords

Canada , ,Health Canada ,European Medicines Agency ,Drug Administration ,Recommended Acceptable Intake Limits ,Nitrosamine Drug Substance Related Impurities ,Predicted Carcinogenic Potency Categorization ,Markets ,